Enzo Diagnostics has been awarded US Patent No. 8,445,664, "Kits for amplifying and detecting nucleic acid sequences."
Elazar Rabbani, Jannis Stavrianopoulos, James Donegan, Jack Coleman, and Marleen Walter are named as inventors.
Beckman said the closing payment for the deal would fixed at $780 million. It also said that it would eliminate Olympus' immunoassay product line and related R&D efforts after the closing of the deal.
The $800 million acquisition will strengthen Beckman Coulter's presence in the clinical chemistry market. The firm does not anticipate a change in its current investment grade ratings due to the new debt.
Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.
Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.
